ALIROCUMAB and DEVICE ISSUE

788 reports of this reaction

1.9% of all ALIROCUMAB reports

#14 most reported adverse reaction

Overview

DEVICE ISSUE is the #14 most commonly reported adverse reaction for ALIROCUMAB, manufactured by Regeneron Pharmaceuticals, Inc.. There are 788 FDA adverse event reports linking ALIROCUMAB to DEVICE ISSUE. This represents approximately 1.9% of all 42,209 adverse event reports for this drug.

Patients taking ALIROCUMAB who experience device issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEVICE ISSUE788 of 42,209 reports

DEVICE ISSUE is a less commonly reported adverse event for ALIROCUMAB, but still significant enough to appear in the safety profile.

Other Side Effects of ALIROCUMAB

In addition to device issue, the following adverse reactions have been reported for ALIROCUMAB:

Other Drugs Associated with DEVICE ISSUE

The following drugs have also been linked to device issue in FDA adverse event reports:

ACLIDINIUM BROMIDEADALIMUMABGUSELKUMABLEVODOPAPEGFILGRASTIMRISANKIZUMAB RZAASOMATROPIN

Frequently Asked Questions

Does ALIROCUMAB cause DEVICE ISSUE?

DEVICE ISSUE has been reported as an adverse event in 788 FDA reports for ALIROCUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEVICE ISSUE with ALIROCUMAB?

DEVICE ISSUE accounts for approximately 1.9% of all adverse event reports for ALIROCUMAB, making it a notable side effect.

What should I do if I experience DEVICE ISSUE while taking ALIROCUMAB?

If you experience device issue while taking ALIROCUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

ALIROCUMAB Full ProfileAll Drugs Causing DEVICE ISSUERegeneron Pharmaceuticals, Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.